Diagnostics

SandboxAQ Collaborates with Mayo Clinic on Novel Cardiac Diagnostics

Clinical research study at leading U.S. hospital will further validate the efficacy of advanced, AI-powered magnetocardiography for transformative cardiac diagnostics…

5 months ago

SphingoTec Closes €5M Series C to Accelerate Market Development and Financial Growth with Innovative Biomarkers

SphingoTec GmbH has successfully secured funding to drive its global expansion, including the US market, through strategic collaborations.The investment round…

5 months ago

Epilog Partners Acquires Care Connectors Medical Group, a Leading Value-Based Care Enablement Platform

DALLAS and NEWPORT BEACH, Calif., Aug. 7, 2024 /PRNewswire/ -- Epilog Partners, a private equity platform built by investors, operators…

5 months ago

Healthcare Sector Sees Steady Rise in VC Investment and Fundraising; Silicon Valley Bank Releases 14th Edition of Mid-Year Healthcare Investments and Exits Report

2024 shaping up to be a strong year for biopharma SAN FRANCISCO, Aug. 7, 2024 /PRNewswire/ -- In the first half…

5 months ago

Abbott Enters Global Partnership to Connect Its World-Leading Continuous Glucose Monitoring System with Medtronic’s Insulin Delivery Devices

Unique partnership with Medtronic will enable continuous glucose monitoring (CGM) sensors based on Abbott's FreeStyle Libre sensing technology to integrate with…

5 months ago

PeopleOne Health Expands Florida Operations with Opening of New Health Center in Palatka

Putnam County Government teams up with PeopleOne Health and RosenCare to deliver barrier-free employee healthcare; opens doors to Palatka health…

5 months ago

PROPHASE LABS INC. TO PRESENT SECOND QUARTER 2024 FINANCIAL RESULTS ON AUGUST 14

GARDEN CITY, NY, Aug. 07, 2024 (GLOBE NEWSWIRE) -- ProPhase Labs Inc. (NASDAQ: PRPH), announced today that they will be…

5 months ago

NewAmsterdam Pharma Provides Corporate Update and Reports Second Quarter Financial Results

-- Reported positive topline data from pivotal Phase 3 BROOKLYN trial evaluating obicetrapib in patients with HeFH; achieved primary endpoint…

5 months ago

Applied DNA to Report Third Quarter Fiscal 2024 Financial Results on Thursday, August 8, 2024

STONY BROOK, NY / ACCESSWIRE / August 7, 2024 / Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"),…

5 months ago